These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 11295713

  • 1. Carvedilol as therapy in pediatric heart failure: an initial multicenter experience.
    Bruns LA, Chrisant MK, Lamour JM, Shaddy RE, Pahl E, Blume ED, Hallowell S, Addonizio LJ, Canter CE.
    J Pediatr; 2001 Apr; 138(4):505-11. PubMed ID: 11295713
    [Abstract] [Full Text] [Related]

  • 2. Carvedilol in children with cardiomyopathy: 3-year experience at a single institution.
    Rusconi P, Gómez-Marín O, Rossique-González M, Redha E, Marín JR, Lon-Young M, Wolff GS.
    J Heart Lung Transplant; 2004 Jul; 23(7):832-8. PubMed ID: 15261177
    [Abstract] [Full Text] [Related]

  • 3. Carvedilol therapy in pediatric patients with dilated cardiomyopathy.
    Askari H, Semizel E, Bostan OM, Cil E.
    Turk J Pediatr; 2009 Jul; 51(1):22-7. PubMed ID: 19378887
    [Abstract] [Full Text] [Related]

  • 4. Effects of carvedilol on left ventricular function and oxidative stress in infants and children with idiopathic dilated cardiomyopathy: a 12-month, two-center, open-label study.
    Bajcetic M, Kokic Nikolic A, Djukic M, Kosutic J, Mitrovic J, Mijalkovic D, Jovanovic I, Simeunovic S, Spasic MB, Samardzic R.
    Clin Ther; 2008 Apr; 30(4):702-14. PubMed ID: 18498919
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effect of carvedilol treatment on chronic heart failure in pediatric patients with dilated cardiomyopathy: a prospective, randomized-controlled study.
    Huang M, Zhang X, Chen S, Sun Y, Xiao Y, Sun J, Huang M, Chen S, Liu F.
    Pediatr Cardiol; 2013 Mar; 34(3):680-5. PubMed ID: 23108482
    [Abstract] [Full Text] [Related]

  • 8. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group.
    Lancet; 1997 Feb 08; 349(9049):375-80. PubMed ID: 9033462
    [Abstract] [Full Text] [Related]

  • 9. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
    Sun YP, Wei CP, Ma SC, Zhang YF, Qiao LY, Li DH, Shan RB.
    J Cardiovasc Pharmacol; 2015 May 08; 65(5):480-4. PubMed ID: 25945865
    [Abstract] [Full Text] [Related]

  • 10. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A, Macdonald PS, Keogh AM, Kotlyar E, Mellemkjaer S, Coleman CF, Elsik M, Krum H, Hayward CS.
    J Am Coll Cardiol; 2010 Apr 27; 55(17):1780-7. PubMed ID: 20413026
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure.
    Macdonald PS, Keogh AM, Aboyoun CL, Lund M, Amor R, McCaffrey DJ.
    J Am Coll Cardiol; 1999 Mar 15; 33(4):924-31. PubMed ID: 10091817
    [Abstract] [Full Text] [Related]

  • 15. Modulation of neurohormonal activity after treatment of children in heart failure with carvedilol.
    Giardini A, Formigari R, Bronzetti G, Prandstraller D, Donti A, Bonvicini M, Picchio FM.
    Cardiol Young; 2003 Aug 15; 13(4):333-6. PubMed ID: 14694952
    [Abstract] [Full Text] [Related]

  • 16. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
    Olsen SL, Gilbert EM, Renlund DG, Taylor DO, Yanowitz FD, Bristow MR.
    J Am Coll Cardiol; 1995 May 15; 25(6):1225-31. PubMed ID: 7722114
    [Abstract] [Full Text] [Related]

  • 17. Carvedilol therapy in pediatric patients with congestive heart failure: a study investigating clinical and pharmacokinetic parameters.
    Läer S, Mir TS, Behn F, Eiselt M, Scholz H, Venzke A, Meibohm B, Weil J.
    Am Heart J; 2002 May 15; 143(5):916-22. PubMed ID: 12040358
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure.
    Palazzuoli A, Bruni F, Puccetti L, Pastorelli M, Angori P, Pasqui AL, Auteri A.
    Eur J Heart Fail; 2002 Dec 15; 4(6):765-70. PubMed ID: 12453548
    [Abstract] [Full Text] [Related]

  • 20. Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.
    Chen L, Meyers D, Javorsky G, Burstow D, Lolekha P, Lucas M, Semmler AB, Savarimuthu SM, Fong KM, Yang IA, Atherton J, Galbraith AJ, Parsonage WA, Molenaar P.
    Pharmacogenet Genomics; 2007 Nov 15; 17(11):941-9. PubMed ID: 18075464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.